Company: LRHC
Filing Date: 2025-09-19
Form Type: 8-K
Source: 0001213900-25-089231
Chunk: 0

Company: La Rosa Holdings Corp.
Filing Date: 2025-09-19
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into
a Material Definitive Agreement.

Amended and Restated
Equity Purchase Facility Agreement

As previously disclosed
in the Current Report on Form 8-K filed by La Rosa Holdings Corp., a Nevada corporation (the “ Company”), with the Securities
and Exchange Commission (the “ SEC”) on August 4, 2025, on August 4, 2025, the Company and an institutional investor (the “ Investor”)
entered into an Equity Purchase Facility Agreement (the “ EPFA”), pursuant to which, upon the terms and subject to the conditions
contained therein, the Company has the right to issue and sell to the Investor from time to time as provided therein, and the Investor
is required to purchase from the Company, up to an aggregate of $150 million (the “ Commitment Amount”) in newly issued shares
of the Company’s common stock, par value $0.0001 per share (the “ Common Shares”).

On August 18, 2025 (“ Agreement
Date”), the Company and the Investor entered into an Amended and Restated Equity Purchase Facility Agreement (“ Amended EPFA”),
pursuant to which the parties agreed to increase the Commitment Amount from $150 million to $1.0 billion Common Shares. The Amended EPFA
amends and restates the EPFA in its entirety. Except for the increase of the Commitment Amount, all material terms and conditions of the Amended EPFA are substantially the same as
those provided in the EPFA.

Pursuant to the
Amended EPFA, the Company is required to provide each stockholder entitled to vote at a meeting of stockholders of the Company (the
“ Stockholder Meeting”), which shall be promptly called and held not later than sixty (60) days after the Agreement Date
(the “ Stockholder Meeting Deadline”), a proxy statement in a form reasonably acceptable to the Investor and counsel, at
the expense of the Company to solicit each of the Company’s stockholders’ affirmative vote at the Stockholder Meeting
for approval of the proposal (“ Stockholder Proposal”) to authorize the issuance of all of the Common Shares issuable
thereunder (in excess of the Commitment Amount that was previously approved by the stockholders of the Company) in compliance with
the rules and regulations of the Nasdaq Capital Market (such affirmative approval being referred to herein as the “ Stockholder
Approval”, and the date such Stockholder Approval is obtained, the “ Stock